In breast cancer, it has been demonstrated that salinomycin can selectively kill E-cadherin-negative breast epithelial cells as compared with E-cadherin-positive cells in NOD/SCID and Balb/c mice model [71]. This evidence concerns the gene CDH1 and breast carcinoma.